Furiex Pharmaceuticals Inc - FURX - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Furiex Pharmaceuticals Inc - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
FURX	Nasdaq	2834	http://furiex.com/	38.50 -0.37
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Furiex Pharmaceuticals Inc FURIEX PHARMACEUTICALS, INC. Financials - May 17th, 2013 11:04 am 5 Healthcare Stock Earnings Snapshots - May 12th, 2013 12:58 pm Narrower-than-Expected Loss at ArQule - May 9th, 2013 10:35 am FURIEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report - May 9th, 2013 7:27 am Furiex Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript - May 8th, 2013 8:30 pm Furiex Pharmaceuticals Earnings: Here’s Why Investors are Not Happy Now - May 7th, 2013 3:46 pm Furiex Reports First Quarter 2013 Financial Results - May 7th, 2013 2:05 pm Furiex Pharmaceuticals: Here’s What Investors Need to Know Before Earnings - May 7th, 2013 9:13 am FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements - May 7th, 2013 7:50 am Q1 2013 Furiex Pharmaceuticals Inc Earnings Release - After Market Close - May 7th, 2013 5:07 am Narrower-than-Expected Loss at Cadence - May 6th, 2013 10:55 am Furiex Pharmaceuticals Announces First Quarter 2013 Earnings Release and Conference Call - Apr 9th, 2013 5:02 pm Furiex Pharmaceuticals Announces First Quarter 2013 Earnings Release and Conference Call - Apr 9th, 2013 2:05 pm FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits - Apr 9th, 2013 7:23 am Pipeline Progresses at Shire - Apr 5th, 2013 1:58 pm 4 Healthcare Stock Stories for Weekend Investment Wellness - Apr 5th, 2013 1:12 pm Setback for Valeant Pharma - Apr 5th, 2013 9:58 am Valeant Ups Offer for Obagi - Apr 4th, 2013 3:18 pm Furiex Pharmaceuticals to Receive Milestone Payment for Priligy® Launch in France - Apr 4th, 2013 7:15 am Setback for Novartis in India - Apr 2nd, 2013 3:13 pm View All Current Headlines >>